NCT01209052 - First Time in Human Study With GSK1325756 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 15, 2009

Primary Completion Date

March 2, 2010

Study Completion Date

March 2, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK1325756

Drug will be orally administered in varying amounts over varying time periods as detailed in the 'arms' section.

OTHER

Placebo

Placebo will be orally administered to at least 4 subjects in each treatment period of each cohort. In each sequence in each cohort, all subjects will receive one dose of placebo.

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London